Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon
Eon Ju Jeon, Kiyoung Lee, Kyoung Kon Kim
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 2, pp. 106-120
Open Access | Times Cited: 23

Showing 23 citing articles:

Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Xin‐Hui Pan, B.C. Tan, Yip Han Chin, et al.
Obesity (2024) Vol. 32, Iss. 5, pp. 840-856
Closed Access | Times Cited: 20
The promise of tirzepatide: A narrative review of metabolic benefits
Sara Sokary, Hiba Bawadi
Primary care diabetes (2025)
Open Access | Times Cited: 1
Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes
Rieko Kanai, Sachiho Kinoshita, Izumi Kanbe, et al.
Obesity Pillars (2024) Vol. 9, pp. 100098-100098
Open Access | Times Cited: 6
Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects
Maurizio De Luca, Amanda Belluzzi, Paulina Salminen, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5106-5106
Open Access | Times Cited: 4
Role of pancreatic lipase inhibition in obesity treatment: mechanisms and challenges towards current insights and future directions
Vetriselvan Subramaniyan, Yusoff Umul Hanim
International Journal of Obesity (2025)
Open Access
Microalgae extracts reduce appetite in zebrafish larvae linked to long-chain fatty acids and 5′-methylthioadenosine
Javier Sanz Moxó, Ana Catarina Fonseca, Gabriela Matos, et al.
Algal Research (2025), pp. 104003-104003
Closed Access
Pharmacological management of obesity in adults: a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy and safety of obesity management medications
Andreea Ciudin, Barbara McGowan, Andreea Ciudin, et al.
Research Square (Research Square) (2025)
Closed Access
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials
Zeyu Xie, Guimei Zheng, Zhuoru Liang, et al.
Metabolism (2024) Vol. 161, pp. 156038-156038
Closed Access | Times Cited: 3
Food Bioactives in the Prevention and Clinical Management of Obesity
Alphonse Laya, Eugénia Carvalho, Iva Fernandes, et al.
(2025), pp. 299-327
Closed Access
Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study
Young Sang Lyu, Hong Yup Ahn, Sangmo Hong, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5255-5268
Open Access | Times Cited: 2
Embracing the Pros and Cons of the New Weight Loss Medications (Semaglutide, Tirzepatide, Etc.)
Mark A. Moyad
Current Urology Reports (2023) Vol. 24, Iss. 11, pp. 515-525
Closed Access | Times Cited: 4
Guidelines for obesity clinic consultations in primary healthcare clinics
Jee‐Hyun Kang, Kyoung Kon Kim
Journal of Korean Medical Association (2024) Vol. 67, Iss. 4, pp. 240-255
Open Access | Times Cited: 1
Bariatric surgery for treatment of morbid obesity in adults
Ki Bum Park, Kyong‐Hwa Jun
The Korean Journal of Internal Medicine (2024) Vol. 40, Iss. 1, pp. 24-39
Open Access | Times Cited: 1
Strategies for Long-Term Weight Loss and Maintenance
Yoo Bin Seo
Korean Journal of Family Practice (2023) Vol. 13, Iss. 3, pp. 128-137
Open Access | Times Cited: 2
NEW TREATMENTS FOR OBESITY: DOUBLE AGONIST TWO GIP/ GLP-1 RECEPTORS – TIRZEPATIDE
Gabrielle Molina Pinto, Mariane Csizmar Gonçalves, Pedro Lucas Silveira Duarte, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 12, pp. 2-9
Open Access
Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison
Koutaro Yokote, Riku Ota, Shogo Wada, et al.
Advances in Therapy (2024) Vol. 41, Iss. 9, pp. 3452-3470
Open Access
A Review on Pharmacological and Non-Pharmacological Therapy for the treatment of Obesity with Cardiovascular Diseases
Anuj Panchal, Anjali Khantal
Research Journal of Pharmacology and Pharmacodynamics (2024), pp. 114-118
Closed Access
Old and new anti-obesity drugs
Salimeh Dodangeh, Shirin Hasani‐Ranjbar
Journal of Diabetes & Metabolic Disorders (2024) Vol. 24, Iss. 1
Closed Access
Common postbariatric surgery emergencies for the acute care surgeon: What you need to know
Vincent Chi‐Chung Cheng, Kamran Samakar, Adrian Dobrowolsky, et al.
Journal of Trauma and Acute Care Surgery (2023) Vol. 95, Iss. 6, pp. 817-831
Open Access | Times Cited: 1
The Transformative Impact of New Anti-Obesity Medications: A Paradigm Shift in Medical Practice?
Arya M. Sharma
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 4, pp. 285-288
Open Access | Times Cited: 1
Multifrequency Low-level Laser-Assisted Lipolysis Outcomes. A Dataset from 101 patients
Gabriel Cubillos-Valencia, N. Vasquez, Andrés Miguel Ortegón Pulido, et al.
Data in Brief (2024) Vol. 57, pp. 111038-111038
Open Access
Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease?
Livio Garattini, Giovanni Fattore
The European Journal of Health Economics (2024)
Closed Access
Güncel Anti-Obezite İlaçları Glukagon benzeri peptid-1 (GLP-1) Reseptör Agonistleri ve Etki Mekanizmaları

(2023)
Open Access
Page 1

Scroll to top